deltatrials
Completed PHASE1 INTERVENTIONAL 1-arm NCT02336321

Daily-life Brain Control Of A Hand Exoskeleton After Cervical Spinal Cord Injury

Restoration of Daily-life Hand Function Using a Brain/Neural-Computer Interaction (BNCI) System in Paralysis After Cervical Spinal Cord Injury

Sponsor: Institut Guttmann

Updated 6 times since 2017 Last updated: May 13, 2015 Started: Apr 30, 2014 Primary completion: Oct 31, 2014 Completion: May 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02336321, this PHASE1 trial focuses on Spinal Cord Injury and remains completed. Sponsored by Institut Guttmann, it has been updated 6 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Sep 2020 · 27 months · monthly snapshotCompleted~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Sep 2020 — Jan 2021 [monthly]

    Completed PHASE1

  5. Jun 2018 — Sep 2020 [monthly]

    Completed PHASE1

Show 1 earlier version
  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1

    First recorded

Apr 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Institut Guttmann
  • Scuola Superiore Sant'Anna di Studi Universitari e di Perfezionamento
  • University Hospital Tuebingen
Data source: University Hospital Tuebingen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations